高级检索
当前位置: 首页 > 详情页

Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission (Open Access)

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China [2]Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China [3]Department of Hematology, Wuhan Central Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [4]Intensive Care Units of Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China [5]Department of Urology Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China [6]Department of Hematology, General Hospital of Central Theater Command, PLA, Wuhan, 300700, China [7]Wuhan Jin-Yin-Tan Hospital, Wuhan, China [8]Medical Records Statistics Department of Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China [9]Center for Hematology Research, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
出处:
ISSN:

摘要:
The impact of cancer on outcome of persons with coronavirus disease 2019 (COVID-19) after infection with acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is controversial. We studied 1859 subjects with COVID-19 from seven centers in Wuhan, China, 65 of whom had cancer. We found having cancer was an independent risk factor for in-hospital death from COVID-19 in persons <65 years (hazard ratio [HR] = 2.45, 95% confidence interval [CI], 1.04, 5.76; P = 0.041) but not in those ≥65 years (HR = 1.12 [0.56, 2.24]; P = 0.740). It was also more common in those not in complete remission. Risks of in-hospital death were similar in subjects with solid cancers and those with hematological cancers. These data may help predict outcomes of persons with cancer and COVID-19. © 2020, The Author(s), under exclusive licence to Springer Nature Limited.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 1 区 医学
小类 | 1 区 血液学 1 区 肿瘤学
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 血液学 1 区 肿瘤学
JCR分区:
出版当年[2018]版:
Q1 ONCOLOGY Q1 HEMATOLOGY
最新[2023]版:
Q1 ONCOLOGY Q1 HEMATOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21166 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)